Optimizing Interdisciplinary Virtual Pain Care and Buprenorphine Initiation During COVID-19: A Quality Improvement Study

Pain Med. 2022 May 30;23(6):1043-1046. doi: 10.1093/pm/pnab348.

Authors

Sara N Edmond^{1

2}, Sophia Currie³, Amanda Gehrke⁴, Caroline G Falker^{1

5}, Minhee Sung^{1

5}, Audrey Abelleira¹, Ellen L Edens^{1

2}, William C Becker^{1

5}

Affiliations

¹ VA Connecticut Healthcare System, West Haven, Connecticut.
² Department of Psychiatry, Yale School of Medicine, New Haven, Connecticut.
³ Yale University, New Haven, Connecticut.
⁴ Bay Pines VA Healthcare System, Lee County VA Health Care Center, Cape Coral, Florida.
⁵ Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut, USA.

No abstract available

Publication types

Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

Analgesics, Opioid / therapeutic use
Buprenorphine* / therapeutic use
COVID-19*
Chronic Pain* / drug therapy
Humans
Opioid-Related Disorders* / drug therapy
Pain / drug therapy
Quality Improvement

Substances

Analgesics, Opioid
Buprenorphine